Back to all news
AI Model Predicts Microsatellite Instability and Immunotherapy Response from Histology
Yonsei University researchers introduced MSI-SEER, an AI model for MSI and immunotherapy response prediction from histology images of gastric and colorectal cancers.
Key Details
- 1MSI-SEER uses deep Gaussian process modeling to analyze H&E-stained whole-slide images.
- 2The model integrates uncertainty quantification, providing a Bayesian Confidence Score for each prediction.
- 3MSI-SEER flags uncertain cases for human review to enhance reliability and safety.
- 4Validated on large, racially diverse datasets, it achieved state-of-the-art MSI prediction accuracy.
- 5The model also predicts immune checkpoint inhibitor (ICI) response, integrating tumor MSI status and stroma-to-tumor ratio.
- 6Published in npj Digital Medicine on May 19, 2025.
Why It Matters
This innovation demonstrates the power of AI in pathology to provide clinically actionable predictions and to integrate uncertainty for safer AI-human collaboration in cancer diagnosis and therapy selection. The approach may serve as a model for broader use of AI in precision oncology workflows.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.